Pseudomonas aeruginosa Post-Operative Peritonitis: Clinical Features, Risk Factors, and Prognosis

被引:15
作者
Augustin, Pascal [1 ]
Dinh, Alexy Tran [1 ]
Valin, Nadia [5 ]
Desmard, Mathieu [1 ]
Crevecoeur, Marie Adeline [1 ]
Muller-Serieys, Claudette [2 ]
Woerther, Paul-Louis [2 ]
Marmuse, Jean-Pierre [3 ,4 ]
Bronchard, Regis [1 ]
Montravers, Philippe [1 ]
机构
[1] Univ Paris Diderot, Sorbonne Paris Cite, Dept Anesthesiol & Intens Care, F-75877 Paris 18, France
[2] Univ Paris Diderot, Sorbonne Paris Cite, Dept Microbiol, Paris, France
[3] Univ Paris Diderot, Sorbonne Paris Cite, Dept Gen Surg, Paris, France
[4] Hop Bichat Claude Bernard, APHP, F-75877 Paris 18, France
[5] Univ Paris 06, Hop St Antoine, APHP, Dept Infect Dis, Paris, France
关键词
VENTILATOR-ASSOCIATED PNEUMONIA; MULTIDRUG-RESISTANT BACTERIA; COMBINATION ANTIBIOTIC-THERAPY; INTRAABDOMINAL INFECTIONS; ANTIMICROBIAL THERAPY; RANDOMIZED-TRIAL; INTENSIVE-CARE; SEPTIC SHOCK; MORTALITY; CANDIDA;
D O I
10.1089/sur.2012.084
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Postoperative peritonitis (PP) is associated with a high rate of multi-drug-resistant micro-organisms. The role of Pseudomonas aeruginosa in this condition has never been assessed. We evaluated the risk factors and prognosis for PP caused by P. aeruginosa. Methods: Patients hospitalized in the intensive care unit (ICU) after re-operation for PP were identified prospectively. Analyses were performed retrospectively. Specific risk factors were investigated by comparing P. aeruginosa PP with PP having other causes. The main outcome endpoint was death in the hospital. Results: We found 55 P. aeruginosa PP among the 349 cases of PP (16%) in the ICU over 14 years. Factors associated with the presence of P. aeruginosa in peritoneal fluid culture were Acute Physiology and Chronic Health Evaluation (APACHE) II score (odds ratio [OR] 1.1; 95% confidence interval [CI] 1.02-1.09; p = 0.004) and respiratory failure (OR 2.3; 95% CI 1.26-4.16; p = 0.006). These criteria performed poorly in predicting P. aeruginosa PP. Such infections were associated with a higher hospital mortality rate, but not after adjustment for the severity score. Adequate antibiotic therapy comprising two antibiotics effective against P. aeruginosa was associated with a lower mortality rate for P. aeruginosa PP in the ICU. Conclusion: The prevalence of P. aeruginosa PP is not high. Risk factors do not allow accurate prediction of the infection. Our data suggest two drugs effective against P. aeruginosa should be considered for treating these infections.
引用
收藏
页码:297 / 303
页数:7
相关论文
共 23 条
[1]   Short term Candida albicans colonization reduces Pseudomonas aeruginosa-related lung injury and bacterial burden in a murine model [J].
Ader, Florence ;
Jawhara, Samir ;
Nseir, Saad ;
Kipnis, Eric ;
Faure, Karine ;
Vuotto, Fanny ;
Chemani, Chanez ;
Sendid, Boualem ;
Poulain, Daniel ;
Guery, Benoit .
CRITICAL CARE, 2011, 15 (03)
[2]   Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis [J].
Augustin, Pascal ;
Kermarrec, Nathalie ;
Muller-Serieys, Claudette ;
Lasocki, Sigismond ;
Chosidow, Denis ;
Marmuse, Jean-Pierre ;
Valin, Nadia ;
Desmonts, Jean-Marie ;
Montravers, Philippe .
CRITICAL CARE, 2010, 14 (01)
[3]  
Brewer C, 1996, CHEST, V109, P1019
[4]   Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia [J].
Chamot, E ;
El Amari, EB ;
Rohner, P ;
Van Delden, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (09) :2756-2764
[5]   Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults - A randomized trial [J].
Chastre, J ;
Wolff, M ;
Fagon, JY ;
Chevret, S ;
Thomas, F ;
Wermert, D ;
Clementi, E ;
Gonzalez, J ;
Jusserand, D ;
Asfar, P ;
Perrin, D ;
Fieux, F ;
Aubas, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (19) :2588-2598
[6]   Enterococci increase the morbidity and mortality associated with severe intra-abdominal infections in elderly patients hospitalized in the intensive care unit [J].
Dupont, Herve ;
Friggeri, Arnaud ;
Touzeau, Jeremy ;
Airapetian, Norair ;
Tinturier, Francois ;
Lobjoie, Eric ;
Lorne, Emmanuel ;
Hijazi, Moustafa ;
Regimbeau, Jean-Marc ;
Mahjoub, Yazine .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (10) :2379-2385
[7]   Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia:: An observational, multicenter study comparing monotherapy with combination antibiotic therapy [J].
Garnacho-Montero, Jose ;
Sa-Borges, Marcio ;
Sole-Violan, Jordi ;
Barcenilla, Fernando ;
Escoresca-Ortega, Ana ;
Ochoa, Miriam ;
Cayuela, Aurelio ;
Rello, Jordi .
CRITICAL CARE MEDICINE, 2007, 35 (08) :1888-1895
[8]   Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia [J].
Heyland, Daren K. ;
Dodek, Peter ;
Muscedere, John ;
Day, Andrew ;
Cook, Deborah ;
Grp, Canadian Crit Care Trials .
CRITICAL CARE MEDICINE, 2008, 36 (03) :737-744
[9]   APACHE-II - A SEVERITY OF DISEASE CLASSIFICATION-SYSTEM [J].
KNAUS, WA ;
DRAPER, EA ;
WAGNER, DP ;
ZIMMERMAN, JE .
CRITICAL CARE MEDICINE, 1985, 13 (10) :818-829
[10]   PROGNOSIS IN ACUTE ORGAN-SYSTEM FAILURE [J].
KNAUS, WA ;
DRAPER, EA ;
WAGNER, DP ;
ZIMMERMAN, JE .
ANNALS OF SURGERY, 1985, 202 (06) :685-693